New Soul music
Avastin Unsuccessful as Adjuvant Therapy in Setting of Stage II and III Colon Cancer but May Be Effective if Given for Longer Duration
Staff Writer
2009-06-01
.www.streetroachpics.com .
Cancer researchers from the National Surgical Adjuvant Breast and Bowel Project (NSABP) and Allegheny General Hospital (AGH) in Pittsburgh reported today at the annual meeting of the American Society of Clinical Oncology (ASCO) in Orlando that use of the drug bevacizumab (Avastin) in combination with standard chemotherapy was not effective in prolonging disease-free survival (DFS) among patients with stage II and stage III colon cancer when given for one year. There is promise that using Avastin for periods longer than one year will lead to improved efficacy. (PRWeb May 31, 2009)
Read the full story at http://www.prweb.com/releases/2009/05/prweb2469724.htm
http://www.prweb.com/releases/2009/05/prweb2469724.htm
